Pharmaceuticals and the developing world
M Kremer - Journal of Economic perspectives, 2002 - aeaweb.org
Pharmaceuticals have greatly improved health in developing countries, but many people in
developing countries do not obtain even inexpensive pharmaceuticals and little …
developing countries do not obtain even inexpensive pharmaceuticals and little …
Public policy issues in direct-to-consumer advertising of prescription drugs
JE Calfee - Journal of Public Policy & Marketing, 2002 - journals.sagepub.com
In August 1997, the Food and Drug Administration (FDA) announced a reinterpretation of its
rules on direct-to-consumer (DTC) advertising, the effect of which was to permit branded …
rules on direct-to-consumer (DTC) advertising, the effect of which was to permit branded …
Social and economic criteria of acceptable risk
N Lind - Reliability Engineering & System Safety, 2002 - Elsevier
A simple normative theory is proposed for the responsible management of risks to the public.
A 'lifesaving'alternative, if it is truly to save lives, should return to the community more years …
A 'lifesaving'alternative, if it is truly to save lives, should return to the community more years …
Outpatient cancer drug costs: changes, drivers, and the future
RJ Halbert, C Zaher, S Wade, J Malin, GD Lawless… - Cancer, 2002 - Wiley Online Library
BACKGROUND To the authors' knowledge, no analysis has examined the specific
components of drug spending for overall cancer care. The authors' objective was to quantify …
components of drug spending for overall cancer care. The authors' objective was to quantify …
Economic messages in prescription drug advertisements in medical journals
PJ Neumann, KZ Bambauer, V Ramakrishnan… - Medical care, 2002 - journals.lww.com
Background. The extent to which pharmaceutical companies promote the economic
advantages of their products in advertisements in medical journals, and whether such claims …
advantages of their products in advertisements in medical journals, and whether such claims …
Cost effectiveness: summary
SP Ringel - Amyotrophic Lateral Sclerosis and Other Motor Neuron …, 2002 - Taylor & Francis
There have been significant advances in medical care, improving life expectancy and quality
of life in the past quarter century, and pharmaceuticals have played a major role in this …
of life in the past quarter century, and pharmaceuticals have played a major role in this …
Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future
PM Danzon, S Soumerai - The 13th Annual Herbert Lourie …, 2002 - papers.ssrn.com
Prescription drug expenditures make up less than 10 percent of total personal health care
expenditures in the United States, but over the last decade the amount that Americans …
expenditures in the United States, but over the last decade the amount that Americans …
Efficiency-based pharmacotherapy: a new approach for decision-making in medical practice
J Soto - Expert Review of Pharmacoeconomics & Outcomes …, 2002 - Taylor & Francis
For many years, efficacy and safety have been key parameters for decision-making in
healthcare policy. However, the current situation is rather different as resources are scarce …
healthcare policy. However, the current situation is rather different as resources are scarce …
[PDF][PDF] EL VALOR DE LES INNOVACIONS MÈDIQUES I FARMACÈUTIQUES: MÉS DINERS, O MÉS SALUT?
J Puig-Junoya, A García-Altésb - Acto conjunto Colegio Médicos …, 2002 - researchgate.net
L'objectiu d'aquest treball és el de proporcionar una descripció i valoració general dels
mètodes i els principals resultats dels diferents enfocs metodològics utilitzats de manera …
mètodes i els principals resultats dels diferents enfocs metodològics utilitzats de manera …
[PDF][PDF] SOCIAL AND ECONOMIC DIMENSIONS OF AN AGING РOPULATION
P Grootendorst, M Levine - 2002 - core.ac.uk
SOCIAL AND ECONOMIC DIMENSIONS OF AN AGING РOPULATION Page 1 SEDAP A
PROGRAM FOR RESEARCH ON SOCIAL AND ECONOMIC DIMENSIONS OF AN AGING …
PROGRAM FOR RESEARCH ON SOCIAL AND ECONOMIC DIMENSIONS OF AN AGING …